Moderna, The Stock That Couldn’t Lose

9 minutes

You're no doubt familiar with Moderna, the Covid-19 Vaccine Maker. Yesterday they announced very poor earnings. We'll explore some of the reasons why.

More episodes from David Reavill

How you can listen to this podcast

You can listen to episodes right here on the website, or if you prefer, in a podcast app. Listening in an app makes it easier to keep track of what you’ve already heard, listen without using your data plan and many other conveniences.

Recommended apps
Start listening to Why Wall Street Fears A Great Financial Crisis 2.0
7:53
Start listening to Why Wall Street Fears A Great Financial Crisis 2.0
7:53